ValuEngine upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a strong sell rating to a sell rating in a report published on Thursday.
Several other equities analysts have also recently commented on the stock. Mizuho set a $37.00 target price on shares of Acadia Healthcare and gave the stock a hold rating in a research report on Thursday. Cantor Fitzgerald reissued a hold rating and set a $39.00 target price on shares of Acadia Healthcare in a research report on Thursday. Craig Hallum cut shares of Acadia Healthcare from a buy rating to a hold rating in a research report on Wednesday. They noted that the move was a valuation call. BidaskClub raised shares of Acadia Healthcare from a strong sell rating to a sell rating in a research report on Saturday, October 6th. Finally, BMO Capital Markets cut shares of Acadia Healthcare from an outperform rating to a market perform rating and set a $45.00 target price on the stock. in a research report on Wednesday, August 1st. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $44.36.
Shares of Acadia Healthcare stock traded down $0.17 during mid-day trading on Thursday, hitting $38.40. 64,228 shares of the stock were exchanged, compared to its average volume of 2,135,865. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $45.27. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 1.20. The stock has a market cap of $3.16 billion, a P/E ratio of 16.99, a P/E/G ratio of 1.28 and a beta of 0.63.
In other news, Director Reeve B. Waud sold 8,135 shares of the firm’s stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $45.00, for a total transaction of $366,075.00. Following the completion of the sale, the director now owns 14,213 shares in the company, valued at approximately $639,585. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.
Several hedge funds have recently modified their holdings of ACHC. Dimensional Fund Advisors LP grew its stake in Acadia Healthcare by 27.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,153,977 shares of the company’s stock valued at $210,849,000 after buying an additional 1,122,452 shares in the last quarter. Copper Rock Capital Partners LLC purchased a new position in Acadia Healthcare in the 2nd quarter valued at approximately $27,394,000. BlackRock Inc. grew its stake in Acadia Healthcare by 2.1% in the 2nd quarter. BlackRock Inc. now owns 10,336,713 shares of the company’s stock valued at $422,875,000 after buying an additional 210,999 shares in the last quarter. State of New Jersey Common Pension Fund D grew its stake in Acadia Healthcare by 22.5% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 980,000 shares of the company’s stock valued at $34,496,000 after buying an additional 180,000 shares in the last quarter. Finally, Rothschild Asset Management Inc. grew its stake in Acadia Healthcare by 21.9% in the 2nd quarter. Rothschild Asset Management Inc. now owns 961,308 shares of the company’s stock valued at $39,327,000 after buying an additional 172,568 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Recommended Story: How to Invest in Growth Stocks
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.